Fund Seeks New Board Members for Orchid Cellmark

A life sciences fund run by Accipiter Capital Management has nominated three new members to be Class I directors on Orchid Cellmark's board.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.